LADX
LadRx Corp
Key Financials
Net Income
$-1589685
↓ 497.0%
Operating Income
$-3623142
↑ 5.2%
Total Assets
$839512.00
↓ 63.6%
Revenue
$250000
0.0%
Total Liabilities
$2.2M
↓ 0.9%
EPS (Diluted)
$-3.21
↓ 572.1%
Shareholders' Equity
$-1419429.00
↓ 1422.2%
Operating Cash Flow
$-1310333.00
↓ 229.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 7/31/2025 | View on SEC |
| 8-K | 6/27/2025 | View on SEC |
| 10-Q | 5/14/2025 | View on SEC |
| 8-K | 4/16/2025 | View on SEC |
| 10-K | 3/28/2025 | View on SEC |
| SEC STAFF ACTION | 2/21/2025 | View on SEC |
| 10-Q | 11/14/2024 | View on SEC |
| 8-K | 10/9/2024 | View on SEC |
| DEFA14A | 8/20/2024 | View on SEC |
| DEF 14A | 8/20/2024 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LADX |
| Company Name | LadRx Corp |
| CIK | 799698 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 310-826-5648 |